InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (3 ops.)
Insider track record
Board DirectorDisclosed buys
3
Disclosed sells
3
T+90 hit rate
67%
T+90 mean return
+25.3%
Across 9 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Pande Atul, Director. Officer active across 2 companies, notably Karuna Therapeutics, Inc.. Aggregated, 35 filings have been logged. Breakdown: 3 buys · 3 sells. Total volume traded: €510k. Activity tracked since 1 April 2021. The latest transaction was filed on 1 April 2025 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations35 total
1,500 sharesCommon StockSEC:0001764013-26-000071:0
1,500 sharesCommon StockSEC:0001764013-26-000071:1
16,188 shares0Common StockSEC:0001764013-25-000047:0
7,750 shares@ US$28.5441.1% of flowCommon StockSEC:0001764013-24-000200:0
11,255 shares0Common StockSEC:0001764013-24-000061:0
990 shares@ US$330.0030.4% of flowCommon StockSEC:0001140361-24-013932:0
4,129 shares@ US$38.8028.8% of flowCommon StockSEC:0001764013-23-000155:0
990 shares0Common StockSEC:0000950170-23-029403:0
12,523 shares0Common StockSEC:0001764013-23-000047:0
15,000 shares@ US$5.6016.7% of flowCommon StockSEC:0001764013-22-000126:0
Ideal exit: 27 Jun 2023 (T+270)
21,059 shares0Common StockSEC:0001764013-22-000095:0
2,500 shares@ US$16.005.2% of flowCommon StockSEC:0001593968-22-000362:0
2,500 shares@ US$16.003.6% of flowCommon StockSEC:0001593968-22-000362
21,726 shares0Common StockSEC:0001764013-22-000015:0
21,726 shares0Common StockSEC:0001764013-22-000015
2,500 shares@ US$16.003.6% of flowCommon StockSEC:0001593968-22-000017
2,500 shares@ US$16.005.1% of flowCommon StockSEC:0001593968-22-000017:0
2,500 shares@ US$16.003.6% of flowCommon StockSEC:0001593968-21-002517
2,500 shares@ US$16.005.1% of flowCommon StockSEC:0001593968-21-002517:0
2,500 shares@ US$16.003.5% of flowCommon StockSEC:0001593968-21-002355
2,500 shares@ US$16.005.0% of flowCommon StockSEC:0001593968-21-002355:0
2,500 shares@ US$16.005.0% of flowCommon StockSEC:0001593968-21-002217:0
2,500 shares@ US$16.003.5% of flowCommon StockSEC:0001593968-21-002217
2,500 shares@ US$16.004.9% of flowCommon StockSEC:0001593968-21-002050:0
2,500 shares@ US$16.003.4% of flowCommon StockSEC:0001593968-21-002050
25 of 35 declarations
About Pande Atul
Atul Pande is an executive at Karuna Therapeutics, Inc.
